Raven biosciences ApS: Financial statements 2025
CVR: 39085127
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Raven biosciences ApS (CVR 39085127) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 6,977,057 and a net result of DKK 1,065,066 compared with DKK -925,200 the year before. That is an increase of 36.9% compared with the year before. The profit margin was 15.3%. Equity in the 2025 report amounted to DKK 2,861,815. The solvency ratio was 52.8%. The company had 9 employees in the financial year.
- Revenue
- DKK 6,977,057
- Gross Profit
- DKK 6,108,076
- Profit/Loss
- DKK 1,065,066
- Equity
- DKK 2,861,815
- Total Assets
- DKK 5,419,586
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 7M | 6.1M | 1.1M | 2.9M | 9 |
| 2024 | 5.1M | 4.1M | -925K | 1.8M | 9 |
| 2023 | 7.1M | 6M | 430K | 3.9M | 7 |
| 2022 | 12.7M | 7.5M | 2.5M | 3.5M | 4 |
| 2021 | 6M | 3.4M | 710K | 1M | - |
Official annual report
How creditworthy is Raven biosciences ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Raven biosciences ApS has published its annual report for 2024. Revenue came to DKK 5,095,382, and the net result was DKK -925,200.
About Raven biosciences ApS
Raven biosciences ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2017. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kenneth Graabek Johansen and Roald Forsberg. The company's owners include Kenneth Graabek Johansen, Roald Forsberg and KGJ Invest ApS. The company has 7 employees (2026). In 2025, the company reported revenue of DKK 6,977,057 and a net result of DKK 1,065,066 compared with DKK -925,200 the year before. Equity in the 2025 report amounted to DKK 2,861,815.